Variant report
Variant | nsv945998 |
---|---|
Chromosome Location | chr1:73564960-73573389 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:46)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:46 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr1:73567904-73567996 | H1-hESC | embryonic stem cell: | n/a | chr1:73567956-73567967 |
2 | CEBPB | chr1:73567817-73568138 | HepG2 | liver: | n/a | chr1:73567956-73567967 |
3 | CTCF | chr1:73566040-73566190 | HL-60 | blood: | n/a | n/a |
4 | CTCF | chr1:73566000-73566150 | HRPEpiC | eye: | n/a | n/a |
5 | CTCF | chr1:73566060-73566210 | WERI-Rb-1 | eye: | n/a | n/a |
6 | CTCF | chr1:73565973-73566213 | T-47D | breast: | n/a | n/a |
7 | CTCF | chr1:73566040-73566190 | Hela-S3 | cervix: | n/a | n/a |
8 | CTCF | chr1:73566107-73566180 | Pancreas_OC | pancreas: | n/a | n/a |
9 | CTCF | chr1:73566055-73566226 | Medullo | brain: | n/a | n/a |
10 | CTCF | chr1:73571640-73571650 | H1-hESC | embryonic stem cell: | n/a | n/a |
11 | CTCF | chr1:73566045-73566210 | HUVEC | blood vessel: | n/a | n/a |
12 | CTCF | chr1:73566037-73566202 | Hela-S3 | cervix: | n/a | n/a |
13 | CTCF | chr1:73565980-73566130 | HMEC | breast: | n/a | n/a |
14 | CTCF | chr1:73565980-73566130 | WERI-Rb-1 | eye: | n/a | n/a |
15 | CTCF | chr1:73566040-73566190 | NHEK | skin: | n/a | n/a |
16 | CTCF | chr1:73571655-73571668 | H1-hESC | embryonic stem cell: | n/a | n/a |
17 | CTCF | chr1:73571600-73571750 | HepG2 | liver: | n/a | n/a |
18 | CTCF | chr1:73565916-73566304 | T-47D | breast: | n/a | n/a |
19 | CTCF | chr1:73566016-73566213 | LNCaP | prostate: | n/a | n/a |
20 | CTCF | chr1:73566060-73566210 | RPTEC | kidney: | n/a | n/a |
21 | CTCF | chr1:73566100-73566250 | HMEC | breast: | n/a | n/a |
22 | CTCF | chr1:73565940-73566090 | RPTEC | kidney: | n/a | n/a |
23 | CTCF | chr1:73566060-73566210 | HRPEpiC | eye: | n/a | n/a |
24 | CTCF | chr1:73566042-73566215 | LNCaP | prostate: | n/a | n/a |
25 | CTCF | chr1:73565941-73566244 | H1-hESC | embryonic stem cell: | n/a | n/a |
26 | CTCF | chr1:73566092-73566156 | MCF-7 | breast: | n/a | n/a |
27 | CTCF | chr1:73565272-73565325 | H1-hESC | embryonic stem cell: | n/a | n/a |
28 | EBF1 | chr1:73565667-73565798 | GM12878 | blood: | n/a | chr1:73565746-73565757 |
29 | GATA3 | chr1:73572705-73572954 | T-47D | breast: | n/a | n/a |
30 | MAX | chr1:73566009-73566191 | NB4 | blood: | n/a | n/a |
31 | MYC | chr1:73565968-73566044 | NB4 | blood: | n/a | n/a |
32 | POLR2A | chr1:73566640-73566718 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | POLR2A | chr1:73571412-73571455 | GM12878 | blood: | n/a | n/a |
34 | POLR2A | chr1:73566339-73566376 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | POLR2A | chr1:73571639-73571689 | MCF-7 | breast: | n/a | n/a |
36 | POLR2A | chr1:73570486-73570592 | A549 | lung: | n/a | n/a |
37 | RAD21 | chr1:73565895-73566293 | H1-hESC | embryonic stem cell: | n/a | n/a |
38 | RAD21 | chr1:73565958-73566185 | SK-N-SH_RA | brain: | n/a | n/a |
39 | RAD21 | chr1:73565945-73566185 | SK-N-SH_RA | brain: | n/a | n/a |
40 | RAD21 | chr1:73565793-73566405 | SK-N-SH | brain: | n/a | n/a |
41 | RAD21 | chr1:73565845-73566236 | H1-hESC | embryonic stem cell: | n/a | n/a |
42 | RAD21 | chr1:73565792-73566284 | H1-hESC | embryonic stem cell: | n/a | n/a |
43 | RAD21 | chr1:73565055-73565444 | H1-hESC | embryonic stem cell: | n/a | n/a |
44 | RAD21 | chr1:73565956-73566283 | Hela-S3 | cervix: | n/a | n/a |
45 | RAD21 | chr1:73565890-73566225 | ECC-1 | luminal epithelium: | n/a | n/a |
46 | SMC3 | chr1:73566006-73566244 | Hela-S3 | cervix: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
KRT8P21 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs60357441 | chr1:73564973-73564974 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs192026828 | chr1:73565001-73565002 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs61029701 | chr1:73565024-73565025 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs58687178 | chr1:73565028-73565029 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs543434789 | chr1:73565227-73565228 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs57345656 | chr1:73565254-73565255 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs375206429 | chr1:73565272-73565273 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs576631335 | chr1:73565293-73565294 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545284266 | chr1:73565294-73565295 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs61767579 | chr1:73565301-73565302 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs527806088 | chr1:73565310-73565311 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541155224 | chr1:73565311-73565312 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561031405 | chr1:73565350-73565351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113658225 | chr1:73565403-73565404 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs201756303 | chr1:73565406-73565407 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs530747418 | chr1:73565434-73565435 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs549718221 | chr1:73565441-73565442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569859999 | chr1:73565482-73565483 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532400366 | chr1:73565530-73565531 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs12729749 | chr1:73565568-73565569 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs565893568 | chr1:73565582-73565583 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534791276 | chr1:73565689-73565690 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs554743502 | chr1:73565697-73565698 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs149263832 | chr1:73565701-73565702 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs183026415 | chr1:73565830-73565831 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs372300941 | chr1:73565874-73565875 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs556877151 | chr1:73565924-73565925 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs576681929 | chr1:73565948-73565949 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs113245179 | chr1:73565952-73565953 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs74225831 | chr1:73565972-73565973 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs114228972 | chr1:73566022-73566023 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs541217461 | chr1:73566027-73566028 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs75369779 | chr1:73566032-73566033 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs561274681 | chr1:73566036-73566037 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs187964625 | chr1:73566075-73566076 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs78959136 | chr1:73566076-73566077 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs563669315 | chr1:73566127-73566128 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs532378298 | chr1:73566177-73566178 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs552475500 | chr1:73566193-73566194 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs139235055 | chr1:73566207-73566208 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs74091275 | chr1:73566313-73566314 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs192916119 | chr1:73566333-73566334 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs565624633 | chr1:73566373-73566374 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs74091277 | chr1:73566400-73566401 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs550328517 | chr1:73566418-73566419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs570456510 | chr1:73566455-73566456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs74091279 | chr1:73566461-73566462 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs551899751 | chr1:73566465-73566466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184135082 | chr1:73566486-73566487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs550139263 | chr1:73566487-73566488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Type 2 diabetes | 21956041 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
abnormal development | 18461090 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Cancer | 22429812 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Schizophrenia | 21346763 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:73562000-73565400 | Enhancers | Fetal Heart | heart |
2 | chr1:73563600-73566200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr1:73563800-73565000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
4 | chr1:73564000-73565200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
5 | chr1:73565000-73566000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr1:73565200-73565400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr1:73565200-73565600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr1:73565200-73565600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr1:73565600-73570600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr1:73566200-73566400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr1:73570600-73571800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr1:73570800-73572000 | ZNF genes & repeats | iPS-15b Cell Line | embryonic stem cell |
13 | chr1:73572000-73580000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |